Scarica l'app Stockscreener
1.66
1.78%
-0.03
Dopo l'orario di chiusura:
1.69
0.03
+1.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CRBU Giù?
Forum
Previsione
Precedente Chiudi:
$1.69
Aprire:
$1.72
Volume 24 ore:
697.29K
Relative Volume:
0.32
Capitalizzazione di mercato:
$155.16M
Reddito:
$34.48M
Utile/perdita netta:
$-102.07M
Rapporto P/E:
-1.137
EPS:
-1.46
Flusso di cassa netto:
$-104.90M
1 W Prestazione:
+4.40%
1M Prestazione:
-11.23%
6M Prestazione:
-5.14%
1 anno Prestazione:
-3.49%
Intervallo 1D:
$1.64
$1.7299
Intervallo di 1 settimana:
$1.54
$1.80
Portata 52W:
$0.66
$3.535
Caribou Biosciences Inc Stock (CRBU) Company Profile
Nome
Caribou Biosciences Inc
Settore
Industria
Telefono
510-982-6030
Indirizzo
2929 7TH STREET, SUITE 105, BERKELEY
Confronta CRBU con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CRBU
Caribou Biosciences Inc
|
1.66 | 157.96M | 34.48M | -102.07M | -104.90M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Caribou Biosciences Inc Stock (CRBU) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-03 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-11-08 | Iniziato | Cantor Fitzgerald | Neutral |
| 2023-10-31 | Iniziato | Evercore ISI | Outperform |
| 2023-07-11 | Iniziato | Truist | Buy |
| 2022-02-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-12-01 | Iniziato | Oppenheimer | Outperform |
| 2021-11-30 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-15 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-08-17 | Iniziato | BofA Securities | Buy |
| 2021-08-17 | Iniziato | Citigroup | Neutral |
| 2021-08-17 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Caribou Biosciences Inc Borsa (CRBU) Ultime notizie
Will Caribou Biosciences Inc. stock benefit from automation2025 Technical Patterns & Consistent Return Strategy Ideas - ulpravda.ru
Why Caribou Biosciences Inc. stock is rated strong buy2025 Market Sentiment & Growth Focused Stock Reports - ulpravda.ru
How sustainable is Caribou Biosciences Inc. stock dividend payoutShort Interest Overview & Superior Growth Investment - bollywoodhelpline.com
How Caribou Biosciences Inc. stock trades before earningsPortfolio Return Report & AI Based Trade Execution Alerts - ulpravda.ru
Can Caribou Biosciences Inc. stock sustain revenue growthM&A Rumor & Risk Adjusted Buy and Sell Alerts - ulpravda.ru
Income Plays: How analysts rate Caribou Biosciences Inc. stock todayMarket Risk Summary & High Conviction Buy Zone Picks - ulpravda.ru
What is the fair value of Caribou Biosciences Inc. stock nowGeopolitical Risk Analysis & Missed Nvidia? Don’t Miss This One - ulpravda.ru
Can Caribou Biosciences Inc. stock continue upward trendMean Reversion Trades & Big Gains Low Budget - ulpravda.ru
Aug Intraday: Can Caribou Biosciences Inc stock sustain revenue growthMarket Weekly Review & Daily Volume Surge Trade Alerts - moha.gov.vn
Caribou Biosciences (CRBU) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Caribou Biosciences Inc stock remain a Wall Street favoriteGold Moves & Low Risk Entry Point Guides - moha.gov.vn
What valuation multiples suggest for Caribou Biosciences Inc. stockGap Fill Strategies & Affordable Growth Investments - bollywoodhelpline.com
Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge - GlobeNewswire
Caribou Biosciences (NASDAQ:CRBU) Trading Up 2.4%Should You Buy? - MarketBeat
Why Caribou Biosciences Inc. stock is popular among millennialsJuly 2025 News Drivers & Weekly Momentum Picks - Улправда
Would You Still Hold Caribou Biosciences Stock If It Fell Another 30%? - Trefis
How analysts rate Caribou Biosciences Inc. stock today2025 Short Interest & Accurate Entry and Exit Point Alerts - DonanımHaber
Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates - sharewise.com
Published on: 2025-12-19 16:09:33 - Улправда
Can Caribou Biosciences Inc. stock sustain institutional interestJuly 2025 Setups & Smart Swing Trading Alerts - DonanımHaber
How risky is Caribou Biosciences Inc. stock nowQuarterly Market Review & Free High Accuracy Swing Entry Alerts - DonanımHaber
Wall Street Recap: Why hedge funds are buying Caribou Biosciences Inc. stock2025 Historical Comparison & Consistent Profit Trading Strategies - Улправда
Targets Report: How sustainable is Caribou Biosciences Inc. stock dividend payoutWeekly Trade Report & Real-Time Volume Trigger Notifications - Улправда
Will Caribou Biosciences Inc. stock remain a Wall Street favoriteM&A Rumor & Reliable Entry Point Alerts - Улправда
Published on: 2025-12-19 08:19:09 - Улправда
Published on: 2025-12-19 00:46:22 - Улправда
What analyst consensus says on Caribou Biosciences Inc. stockJuly 2025 Action & High Accuracy Buy Signal Tips - Улправда
Market Overview: Why Caribou Biosciences Inc. stock is a value investor pickJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - Улправда
Chart Watch: How risky is Caribou Biosciences Inc stock nowWeekly Trade Review & AI Enhanced Trading Alerts - moha.gov.vn
Caribou Biosciences Earnings Notes - Trefis
Published on: 2025-12-14 05:29:10 - earlytimes.in
Bank of America Securities Sticks to Their Buy Rating for Caribou Biosciences (CRBU) - The Globe and Mail
Will Caribou Biosciences Inc. stock reach Wall Street targets2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Caribou Biosciences Target of Unusually Large Options Trading (NASDAQ:CRBU) - MarketBeat
Caribou Biosciences to Host Expert Panel on Access Expansion for vispa-cel CAR-T Therapy at ASH Annual Meeting - Quiver Quantitative
Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025 - 富途牛牛
MACD Signal: Will ABEV stock outperform value stocksJuly 2025 Earnings & Accurate Intraday Trading Signals - BỘ NỘI VỤ
Earnings Risk: What analyst consensus says on Caribou Biosciences Inc stockJuly 2025 Pullbacks & Free Daily Entry Point Trade Alerts - BỘ NỘI VỤ
Caribou Biosciences CEO to address Evercore Healthcare Conference - Traders Union
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Caribou Biosciences, Inc. $CRBU Shares Bought by Envestnet Asset Management Inc. - MarketBeat
Caribou Biosciences signals access challenge in CAR-T cell therapy - Traders Union
Analyzing Caribou Biosciences Inc. with multi timeframe chartsJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com
Caribou Biosciences Inc Azioni (CRBU) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Caribou Biosciences Inc Azioni (CRBU) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| MCCLUNG BARBARA G | Chief Legal Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
443,502 |
| Khan Ruhi Ahmad | Chief Business Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
66,936 |
| Kanner Steven | Chief Scientific Officer |
Feb 21 '25 |
Sale |
1.35 |
3,564 |
4,811 |
431,556 |
| Ryali Sriram | Chief Financial Officer |
Jan 29 '25 |
Buy |
1.42 |
17,360 |
24,651 |
17,360 |
0.90%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):